Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging

NCT00709852 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Diagnostic Imaging
Central Nervous System Diseases

Interventions

DRUG: Gadobutrol (Gadavist, Gadovist, BAY86-4875)
DRUG: Gadoteridol (ProHance)

Sponsor

Bayer